TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 79 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $21,000 | -19.2% | 410 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $26,000 | -13.3% | 410 | 0.0% | 0.00% | -40.0% |
Q2 2021 | $30,000 | 0.0% | 410 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $30,000 | 0.0% | 410 | 0.0% | 0.01% | -16.7% |
Q4 2020 | $30,000 | +36.4% | 410 | 0.0% | 0.01% | +20.0% |
Q3 2020 | $22,000 | -18.5% | 410 | 0.0% | 0.01% | -16.7% |
Q2 2020 | $27,000 | +8.0% | 410 | 0.0% | 0.01% | 0.0% |
Q1 2020 | $25,000 | -30.6% | 410 | 0.0% | 0.01% | -25.0% |
Q4 2019 | $36,000 | +16.1% | 410 | 0.0% | 0.01% | +14.3% |
Q3 2019 | $31,000 | -11.4% | 410 | 0.0% | 0.01% | -12.5% |
Q2 2019 | $35,000 | -20.5% | 410 | 0.0% | 0.01% | -20.0% |
Q1 2019 | $44,000 | +780.0% | 410 | +831.8% | 0.01% | +400.0% |
Q4 2017 | $5,000 | 0.0% | 44 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $5,000 | 0.0% | 44 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $5,000 | – | 44 | +1000.0% | 0.00% | – |
Q1 2017 | $0 | -100.0% | 4 | -86.7% | 0.00% | -100.0% |
Q4 2016 | $3,000 | – | 30 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Claret Asset Management Corp | 86,474 | $6,524,000 | 1.34% |
Analyst IMS Investment Management Services Ltd. | 28,438 | $2,143,000 | 0.64% |
ALGERT GLOBAL LLC | 20,876 | $1,575,000 | 0.59% |
Quantinno Capital Management LP | 9,351 | $706,000 | 0.48% |
Crestline Management, LP | 37,000 | $2,792,000 | 0.45% |
Empirical Finance, LLC | 9,561 | $721,000 | 0.20% |
BRANDES INVESTMENT PARTNERS, LP | 55,065 | $5,469,000 | 0.14% |
FORT, L.P. | 9,672 | $730,000 | 0.14% |
CAXTON ASSOCIATES LP | 8,865 | $669,000 | 0.13% |
ACADIAN ASSET MANAGEMENT LLC | 330,448 | $24,928,000 | 0.11% |